Cotadutide, a GLP-1 agonist, has alleviated fibrosis more significantly than liraglutide or obeticholic acid and exhibits weight loss in diabetes in two preclinical mouse models of NASH [185]. The gene discussed is GLP1R; the disease is diabetes mellitus.